All case studies
Research

MRI System Launch

A new MRI system was ready for engineering sign-off, but the launch price was anchored to build cost rather than to what the market would pay. We tested who would buy, why they would switch, and what they would actually pay, then set the price and the go-to-market playbook on evidence before a single unit shipped.

$14.2M projected first-year revenue
MRI System Launch

At a glance

Client

Medical imaging manufacturer

Sector

Healthcare / Medical devices

Engagement

Market, concept & price testing

Timeline

10 weeks

The challenge

A high-stakes launch built on assumptions

The system was a seven-figure capital purchase with an 18-month sales cycle, sold into hospitals and private imaging centers against entrenched incumbents like the big three OEMs. Engineering was strong, but there was no evidence on who would buy, why they would switch, or what they would pay. Reps were improvising discounts deal by deal, and a single mispriced launch risked anchoring the product too low for years.

Our process

What we did

  1. 01

    Market & segmentation

    Ran 30 in-depth interviews with radiologists, biomedical engineers, and procurement leads across six markets to map buying centers, switching triggers, and decision criteria.

  2. 02

    Competitive teardown

    Benchmarked five incumbent systems on specs, service contracts, and street pricing to find the unclaimed white space.

  3. 03

    Concept testing

    Tested three value-proposition framings (image quality, throughput, total cost of ownership) with 200+ clinical and financial stakeholders.

  4. 04

    Price testing

    Combined a Van Westendorp price-sensitivity study with conjoint analysis to find the price the market would actually bear and the willingness to pay for each configuration.

  5. 05

    Launch playbook

    Delivered positioning, three priority segments, a configuration-level price ladder, and discount guardrails the sales team could hold to.

The results

$14.2M

projected first-year revenue across 3 priority segments

+14%

higher launch price than the cost-based floor, set on evidence

31%

forecast win rate vs incumbents, up from 19%

+22%

willingness-to-pay headroom the market would bear above plan

47%

conjoint share-of-preference for the lead configuration

−9 pts

discount leakage cut, from 17% to 8% of deal value

Could your numbers tell a story like this?

Book a Consultation